Tokyo, Dec. 16 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060087) titled 'The riskfactor of postherpetic neuralgia' on Dec. 15.
Study Type:
Observational
Primary Sponsor:
Institute - Osaka Metropolitan University
Condition:
Condition - Herpes zoster, Herpes zoster-associated pain, Postherpetic neuralgia
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The aim of this study is to prospectively investigate risk factors leading to the development of postherpetic neuralgia (PHN) among patients with herpes zoster, with a particular focus on elucidating the impact of patient frailty status on the onset of PHN. By doing so, we seek to establish scientific evidence for PHN risk stratification and preventive interventions, ultimately contributing to improved pain management and the maintenance of functional capacity in older adults.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients aged 18 years or older who are within 3 months of herpes zoster onset at the time of consent
Patients who are able to provide informed consent to participate in the study
Key exclusion criteria - Patients already diagnosed with chronic pain in whom the initial pain screening makes it difficult to determine whether the pain is related to herpes zoster
Patients who are expected to be difficult to follow up
Patients with deformities or a history of surgery in the lower limbs or measurement sites that prevent accurate gait assessments or muscle thickness measurements
Target Size - 200
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 12 Month 15 Day
Anticipated trial start date - 2025 Year 12 Month 22 Day
Last follow-up date - 2030 Year 12 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068641
Disclaimer: Curated by HT Syndication.
